Aslani, Jack Perez .

HRN: 22-76-89  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/18/2024
10/24/2024
IVT
300mg
Q6
Pneumonia
Waiting Final Action 
10/21/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/21/2024
10/28/2024
IV
80 Mg
Q 8 Hours
AGE; PCAP-C
Waiting Final Action 
10/23/2024
CEFUROXIME 750MG (VIAL)
10/23/2024
10/29/2024
IV
270mg
Q8h
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: